Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Olanzapine in treatment-resistant bipolar disorder.

McElroy SL, Frye M, Denicoff K, Altshuler L, Nolen W, Kupka R, Suppes T, Keck PE Jr, Leverich GS, Kmetz GF, Post RM.

J Affect Disord. 1998 May;49(2):119-22.

PMID:
9609675
2.

Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders.

Janenawasin S, Wang PW, Lembke A, Schumacher M, Das B, Santosa CM, Mongkolcheep J, Ketter TA.

Bipolar Disord. 2002 Oct;4(5):328-34.

PMID:
12479666
3.

Does olanzapine have antidepressant properties? A retrospective preliminary study.

Ghaemi SN, Cherry EL, Katzow JA, Goodwin FK.

Bipolar Disord. 2000 Sep;2(3 Pt 1):196-9.

PMID:
11256687
4.

Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder.

Vieta E, Reinares M, Corbella B, Benabarre A, Gilaberte I, Colom F, Martínez-Arán A, Gastó C, Tohen M.

J Clin Psychopharmacol. 2001 Oct;21(5):469-73.

PMID:
11593070
5.

Mood stabilizer augmentation with olanzapine in acutely manic children.

Chang KD, Ketter TA.

J Child Adolesc Psychopharmacol. 2000 Spring;10(1):45-9.

PMID:
10755582
6.

A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder.

Frazier JA, Biederman J, Tohen M, Feldman PD, Jacobs TG, Toma V, Rater MA, Tarazi RA, Kim GS, Garfield SB, Sohma M, Gonzalez-Heydrich J, Risser RC, Nowlin ZM.

J Child Adolesc Psychopharmacol. 2001 Fall;11(3):239-50.

PMID:
11642474
7.

Treatment of bipolar mixed state with olanzapine.

Sharma V, Pistor L.

J Psychiatry Neurosci. 1999 Jan;24(1):40-4.

8.

Olanzapine: a review of its use in the treatment of bipolar I disorder.

Bhana N, Perry CM.

CNS Drugs. 2001;15(11):871-904. Review.

PMID:
11700151
9.

Olanzapine compared to lithium in mania: a double-blind randomized controlled trial.

Berk M, Ichim L, Brook S.

Int Clin Psychopharmacol. 1999 Nov;14(6):339-43.

PMID:
10565800
10.

Olanzapine response in psychotic depression.

Rothschild AJ, Bates KS, Boehringer KL, Syed A.

J Clin Psychiatry. 1999 Feb;60(2):116-8.

PMID:
10084638
11.

Olanzapine in the treatment of adolescent acute mania: a report of seven cases.

Soutullo CA, Sorter MT, Foster KD, McElroy SL, Keck PE.

J Affect Disord. 1999 Jun;53(3):279-83.

PMID:
10404715
12.

Effective open-label treatment of tourette's disorder with olanzapine.

Stamenkovic M, Schindler SD, Aschauer HN, De Zwaan M, Willinger U, Resinger E, Kasper S.

Int Clin Psychopharmacol. 2000 Jan;15(1):23-8.

PMID:
10836282
13.

Clinical predictors of acute response with olanzapine in psychotic mood disorders.

Zarate CA Jr, Narendran R, Tohen M, Greaney JJ, Berman A, Pike S, Madrid A.

J Clin Psychiatry. 1998 Jan;59(1):24-8.

PMID:
9491062
14.

Is olanzapine a mood stabilizer?

Ananth J.

Can J Psychiatry. 1999 Nov;44(9):927-8. No abstract available.

PMID:
10584170
15.

Treatment of bipolar I disorder in an adolescent with olanzapine.

Khouzam HR, El-Gabalawi F.

J Child Adolesc Psychopharmacol. 2000 Summer;10(2):147-51.

PMID:
10933124
16.

Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study.

Potenza MN, Holmes JP, Kanes SJ, McDougle CJ.

J Clin Psychopharmacol. 1999 Feb;19(1):37-44.

PMID:
9934941
17.

Use of olanzapine in dysphoric mania.

Gonzalez-Pinto A, Lalaguna B, Mosquera F, Pérez de Heredia JL, Gutierrez M, Ezcurra J, Gilaberte I, Tohen M.

J Affect Disord. 2001 Oct;66(2-3):247-53.

PMID:
11578678
18.

Open-label olanzapine treatment in five preadolescent children.

Krishnamoorthy J, King BH.

J Child Adolesc Psychopharmacol. 1998;8(2):107-13.

PMID:
9730076
19.

Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group.

Tohen M, Sanger TM, McElroy SL, Tollefson GD, Chengappa KN, Daniel DG, Petty F, Centorrino F, Wang R, Grundy SL, Greaney MG, Jacobs TG, David SR, Toma V.

Am J Psychiatry. 1999 May;156(5):702-9.

PMID:
10327902
20.

Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling.

Sanger TM, Tohen M, Vieta E, Dunner DL, Bowden CL, Calabrese JR, Feldman PD, Jacobs TG, Breier A.

J Affect Disord. 2003 Jan;73(1-2):155-61.

PMID:
12507748

Supplemental Content

Support Center